Basel, 31 March 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Elecsys® EBV panel has launched in countries accepting the CE Mark. Roche will file for approval with the FDA in the ...
Dr. Todd Maderis, ND Exploring immune dysregulation, viral reactivation, mitochondrial impairment, and treatment implications in post-EBV fatigue syndromes ...
Durham, NC - A relationship between Epstein-Barr virus (EBV) infection and development of systemic lupus erythematosus (SLE) has long been suspected, but since 90% of adults show signs of latent EBV, ...
In a recent study published in the journal PLOS Pathogens, researchers investigated humoral and cell-mediated immune responses to Epstein-Barr virus (EBV) in multiple sclerosis (MS) patients, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results